What does Harpoon Therapeutics, Inc. do?

Jun 22 2025 06:57 PM IST
share
Share Via
Harpoon Therapeutics, Inc. is a clinical-stage immunotherapy company focused on T cell engagers for cancer treatment. As of September 2023, it reported net sales of $4 million and a net loss of $2 million, with a market cap of $492.35 million.
Overview:
Harpoon Therapeutics, Inc. is a clinical-stage immunotherapy company in the biotechnology industry, focusing on T cell engagers to treat cancer and other diseases. Financial Snapshot: Net Sales: 4 Million (Quarterly Results - Sep 2023) Net Profit: -2 Million (Quarterly Results - Sep 2023) Market cap: USD 492.35 Million (Micro Cap) Key Metrics: P/E: NA (Loss Making) Industry P/E: NA Dividend Yield: 181.12% Debt Equity: -6.31 Return on Equity: -380.31% Price to Book: 108.42 Contact Details: Address: 131 Oyster Point Blvd Ste 300, SOUTH SAN FRANCISCO CA 94080-1910 Tel: 1 650 4437400 Website: https://www.harpoontx.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
How big is Harpoon Therapeutics, Inc.?
Jun 22 2025 06:11 PM IST
share
Share Via